1 Market Overview

1.1 Product Overview and Scope of COVID-19 Drugs

1.2 Classification of COVID-19 Drugs by Type

1.2.1 Overview: Global COVID-19 Drugs Market Size by Type: 2022 Versus 2028

1.2.2 Global COVID-19 Drugs Revenue Market Share by Type in 2028

1.2.3 Tablet

1.2.4 Injection

1.3 Global COVID-19 Drugs Market by Application

1.3.1 Overview: Global COVID-19 Drugs Market Size by Application: 2022 Versus 2028

1.3.2 Mild Symptom Patient

1.3.3 Critically Ill Patient

1.4 Global COVID-19 Drugs Market Size & Forecast

1.5 Market Drivers, Restraints and Trends

1.5.1 COVID-19 Drugs Market Drivers

1.5.2 COVID-19 Drugs Market Restraints

1.5.3 COVID-19 Drugs Trends Analysis

2 Company Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business

2.1.3 Sanofi COVID-19 Drugs Product and Solutions

2.1.4 Sanofi Recent Developments and Future Plans

2.2 Novartis

2.2.1 Novartis Details

2.2.2 Novartis Major Business

2.2.3 Novartis COVID-19 Drugs Product and Solutions

2.2.4 Novartis Recent Developments and Future Plans

2.3 Shanghai Zhongxisanwei

2.3.1 Shanghai Zhongxisanwei Details

2.3.2 Shanghai Zhongxisanwei Major Business

2.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Product and Solutions

2.3.4 Shanghai Zhongxisanwei Recent Developments and Future Plans

2.4 Teva

2.4.1 Teva Details

2.4.2 Teva Major Business

2.4.3 Teva COVID-19 Drugs Product and Solutions

2.4.4 Teva Recent Developments and Future Plans

2.5 Zydus Cadila

2.5.1 Zydus Cadila Details

2.5.2 Zydus Cadila Major Business

2.5.3 Zydus Cadila COVID-19 Drugs Product and Solutions

2.5.4 Zydus Cadila Recent Developments and Future Plans

2.6 Mylan

2.6.1 Mylan Details

2.6.2 Mylan Major Business

2.6.3 Mylan COVID-19 Drugs Product and Solutions

2.6.4 Mylan Recent Developments and Future Plans

2.7 Apotex

2.7.1 Apotex Details

2.7.2 Apotex Major Business

2.7.3 Apotex COVID-19 Drugs Product and Solutions

2.7.4 Apotex Recent Developments and Future Plans

2.8 Advanz Pharma

2.8.1 Advanz Pharma Details

2.8.2 Advanz Pharma Major Business

2.8.3 Advanz Pharma COVID-19 Drugs Product and Solutions

2.8.4 Advanz Pharma Recent Developments and Future Plans

2.9 Sun Pharma

2.9.1 Sun Pharma Details

2.9.2 Sun Pharma Major Business

2.9.3 Sun Pharma COVID-19 Drugs Product and Solutions

2.9.4 Sun Pharma Recent Developments and Future Plans

2.10 Kyung Poong

2.10.1 Kyung Poong Details

2.10.2 Kyung Poong Major Business

2.10.3 Kyung Poong COVID-19 Drugs Product and Solutions

2.10.4 Kyung Poong Recent Developments and Future Plans

2.11 Ipca Laboratories

2.11.1 Ipca Laboratories Details

2.11.2 Ipca Laboratories Major Business

2.11.3 Ipca Laboratories COVID-19 Drugs Product and Solutions

2.11.4 Ipca Laboratories Recent Developments and Future Plans

2.12 Hanlim Pharmaceutical

2.12.1 Hanlim Pharmaceutical Details

2.12.2 Hanlim Pharmaceutical Major Business

2.12.3 Hanlim Pharmaceutical COVID-19 Drugs Product and Solutions

2.12.4 Hanlim Pharmaceutical Recent Developments and Future Plans

2.13 Bristol Laboratories

2.13.1 Bristol Laboratories Details

2.13.2 Bristol Laboratories Major Business

2.13.3 Bristol Laboratories COVID-19 Drugs Product and Solutions

2.13.4 Bristol Laboratories Recent Developments and Future Plans

2.14 Bayer

2.14.1 Bayer Details

2.14.2 Bayer Major Business

2.14.3 Bayer COVID-19 Drugs Product and Solutions

2.14.4 Bayer Recent Developments and Future Plans

2.15 Rising Pharmaceutical

2.15.1 Rising Pharmaceutical Details

2.15.2 Rising Pharmaceutical Major Business

2.15.3 Rising Pharmaceutical COVID-19 Drugs Product and Solutions

2.15.4 Rising Pharmaceutical Recent Developments and Future Plans

2.16 Shanghai Pharma

2.16.1 Shanghai Pharma Details

2.16.2 Shanghai Pharma Major Business

2.16.3 Shanghai Pharma COVID-19 Drugs Product and Solutions

2.16.4 Shanghai Pharma Recent Developments and Future Plans

2.17 Sichuan Sunny Hope

2.17.1 Sichuan Sunny Hope Details

2.17.2 Sichuan Sunny Hope Major Business

2.17.3 Sichuan Sunny Hope COVID-19 Drugs Product and Solutions

2.17.4 Sichuan Sunny Hope Recent Developments and Future Plans

2.18 Guangzhou Baiyunshan Guanghua Pharmaceutical

2.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details

2.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business

2.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product and Solutions

2.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans

2.19 CSPC Group

2.19.1 CSPC Group Details

2.19.2 CSPC Group Major Business

2.19.3 CSPC Group COVID-19 Drugs Product and Solutions

2.19.4 CSPC Group Recent Developments and Future Plans

2.20 KPC Group

2.20.1 KPC Group Details

2.20.2 KPC Group Major Business

2.20.3 KPC Group COVID-19 Drugs Product and Solutions

2.20.4 KPC Group Recent Developments and Future Plans

2.21 Jinghua Pharmaceutical Group

2.21.1 Jinghua Pharmaceutical Group Details

2.21.2 Jinghua Pharmaceutical Group Major Business

2.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Product and Solutions

2.21.4 Jinghua Pharmaceutical Group Recent Developments and Future Plans

2.22 Zhongsheng Pharma

2.22.1 Zhongsheng Pharma Details

2.22.2 Zhongsheng Pharma Major Business

2.22.3 Zhongsheng Pharma COVID-19 Drugs Product and Solutions

2.22.4 Zhongsheng Pharma Recent Developments and Future Plans

2.23 North China Pharmaceutical Group

2.23.1 North China Pharmaceutical Group Details

2.23.2 North China Pharmaceutical Group Major Business

2.23.3 North China Pharmaceutical Group COVID-19 Drugs Product and Solutions

2.23.4 North China Pharmaceutical Group Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global COVID-19 Drugs Revenue and Share by Players (2022 & 2028)

3.2 COVID-19 Drugs Players Head Office, Products and Services Provided

3.3 COVID-19 Drugs Mergers & Acquisitions

3.4 COVID-19 Drugs New Entrants and Expansion Plans

4 Global COVID-19 Drugs Forecast by Region

4.1 Global COVID-19 Drugs Market Size by Region: 2022 VS 2028

4.2 Global COVID-19 Drugs Market Size by Region, (2022-2028)

4.3 North America

4.3.1 Key Companies of COVID-19 Drugs in North America

4.3.2 Current Situation and Forecast of COVID-19 Drugs in North America

4.3.3 North America COVID-19 Drugs Market Size and Prospect (2022-2028)

4.4 Europe

4.4.1 Key Companies of COVID-19 Drugs in Europe

4.4.2 Current Situation and Forecast of COVID-19 Drugs in Europe

4.4.3 Europe COVID-19 Drugs Market Size and Prospect (2022-2028)

4.5 Asia-Pacific

4.5.1 Key Companies of COVID-19 Drugs in Asia-Pacific

4.5.2 Current Situation and Forecast of COVID-19 Drugs in Asia-Pacific

4.5.3 Asia-Pacific COVID-19 Drugs Market Size and Prospect (2022-2028)

4.6 South America

4.6.1 Key Companies of COVID-19 Drugs in South America

4.6.2 Current Situation and Forecast of COVID-19 Drugs in South America

4.6.3 South America COVID-19 Drugs Market Size and Prospect (2022-2028)

4.7 Middle East & Africa

4.7.1 Key Companies of COVID-19 Drugs in Middle East & Africa

4.7.2 Current Situation and Forecast of COVID-19 Drugs in Middle East & Africa

4.7.3 Middle East & Africa COVID-19 Drugs Market Size and Prospect (2022-2028)

5 Market Size Segment by Type

5.1 Global COVID-19 Drugs Market Forecast by Type (2022-2028)

5.2 Global COVID-19 Drugs Market Share Forecast by Type (2022-2028)

6 Market Size Segment by Application

6.1 Global COVID-19 Drugs Market Forecast by Application (2022-2028)

6.2 Global COVID-19 Drugs Market Share Forecast by Application (2022-2028)

7 Research Findings and Conclusion

8 Appendix

8.1 Methodology

8.2 Research Process and Data Source

8.3 Disclaimer

List of Tables

Table 1. Global COVID-19 Drugs Revenue by Type, (USD Million), 2022 VS 2028

Table 2. Global COVID-19 Drugs Revenue by Application, (USD Million), 2022 VS 2028

Table 3. Sanofi Corporate Information, Head Office, and Major Competitors

Table 4. Sanofi Major Business

Table 5. Sanofi COVID-19 Drugs Product and Solutions

Table 6. Novartis Corporate Information, Head Office, and Major Competitors

Table 7. Novartis Major Business

Table 8. Novartis COVID-19 Drugs Product and Solutions

Table 9. Shanghai Zhongxisanwei Corporate Information, Head Office, and Major Competitors

Table 10. Shanghai Zhongxisanwei Major Business

Table 11. Shanghai Zhongxisanwei COVID-19 Drugs Product and Solutions

Table 12. Teva Corporate Information, Head Office, and Major Competitors

Table 13. Teva Major Business

Table 14. Teva COVID-19 Drugs Product and Solutions

Table 15. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 16. Zydus Cadila Major Business

Table 17. Zydus Cadila COVID-19 Drugs Product and Solutions

Table 18. Mylan Corporate Information, Head Office, and Major Competitors

Table 19. Mylan Major Business

Table 20. Mylan COVID-19 Drugs Product and Solutions

Table 21. Apotex Corporate Information, Head Office, and Major Competitors

Table 22. Apotex Major Business

Table 23. Apotex COVID-19 Drugs Product and Solutions

Table 24. Advanz Pharma Corporate Information, Head Office, and Major Competitors

Table 25. Advanz Pharma Major Business

Table 26. Advanz Pharma COVID-19 Drugs Product and Solutions

Table 27. Sun Pharma Corporate Information, Head Office, and Major Competitors

Table 28. Sun Pharma Major Business

Table 29. Sun Pharma COVID-19 Drugs Product and Solutions

Table 30. Kyung Poong Corporate Information, Head Office, and Major Competitors

Table 31. Kyung Poong Major Business

Table 32. Kyung Poong COVID-19 Drugs Product and Solutions

Table 33. Ipca Laboratories Corporate Information, Head Office, and Major Competitors

Table 34. Ipca Laboratories Major Business

Table 35. Ipca Laboratories COVID-19 Drugs Product and Solutions

Table 36. Hanlim Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 37. Hanlim Pharmaceutical Major Business

Table 38. Hanlim Pharmaceutical COVID-19 Drugs Product and Solutions

Table 39. Bristol Laboratories Corporate Information, Head Office, and Major Competitors

Table 40. Bristol Laboratories Major Business

Table 41. Bristol Laboratories COVID-19 Drugs Product and Solutions

Table 42. Bayer Corporate Information, Head Office, and Major Competitors

Table 43. Bayer Major Business

Table 44. Bayer COVID-19 Drugs Product and Solutions

Table 45. Rising Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 46. Rising Pharmaceutical Major Business

Table 47. Rising Pharmaceutical COVID-19 Drugs Product and Solutions

Table 48. Shanghai Pharma Corporate Information, Head Office, and Major Competitors

Table 49. Shanghai Pharma Major Business

Table 50. Shanghai Pharma COVID-19 Drugs Product and Solutions

Table 51. Sichuan Sunny Hope Corporate Information, Head Office, and Major Competitors

Table 52. Sichuan Sunny Hope Major Business

Table 53. Sichuan Sunny Hope COVID-19 Drugs Product and Solutions

Table 54. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 55. Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business

Table 56. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product and Solutions

Table 57. CSPC Group Corporate Information, Head Office, and Major Competitors

Table 58. CSPC Group Major Business

Table 59. CSPC Group COVID-19 Drugs Product and Solutions

Table 60. KPC Group Corporate Information, Head Office, and Major Competitors

Table 61. KPC Group Major Business

Table 62. KPC Group COVID-19 Drugs Product and Solutions

Table 63. Jinghua Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 64. Jinghua Pharmaceutical Group Major Business

Table 65. Jinghua Pharmaceutical Group COVID-19 Drugs Product and Solutions

Table 66. Zhongsheng Pharma Corporate Information, Head Office, and Major Competitors

Table 67. Zhongsheng Pharma Major Business

Table 68. Zhongsheng Pharma COVID-19 Drugs Product and Solutions

Table 69. North China Pharmaceutical Group Corporate Information, Head Office, and Major Competitors

Table 70. North China Pharmaceutical Group Major Business

Table 71. North China Pharmaceutical Group COVID-19 Drugs Product and Solutions

Table 72. Global COVID-19 Drugs Revenue (USD Million) by Players (2022 & 2028)

Table 73. Global COVID-19 Drugs Revenue Share by Players (2022 & 2028)

Table 74. COVID-19 Drugs Players Head Office, Products and Services Provided

Table 75. COVID-19 Drugs Mergers & Acquisitions in the Past Five Years

Table 76. COVID-19 Drugs New Entrants and Expansion Plans

Table 77. Global Market COVID-19 Drugs Revenue (USD Million) Comparison by Region (2022 VS 2028)

Table 78. Global COVID-19 Drugs Revenue Market Share by Region (2022-2028)

Table 79. Key Companies of COVID-19 Drugs in North America

Table 80. Current Situation and Forecast of COVID-19 Drugs in North America

Table 81. Key Companies of COVID-19 Drugs in Europe

Table 82. Current Situation and Forecast of COVID-19 Drugs in Europe

Table 83. Key Companies of COVID-19 Drugs in Asia-Pacific

Table 84. Current Situation and Forecast of COVID-19 Drugs in Asia-Pacific

Table 85. Key Companies of COVID-19 Drugs in China

Table 86. Key Companies of COVID-19 Drugs in Japan

Table 87. Key Companies of COVID-19 Drugs in South Korea

Table 88. Key Companies of COVID-19 Drugs in South America

Table 89. Current Situation and Forecast of COVID-19 Drugs in South America

Table 90. Key Companies of COVID-19 Drugs in Middle East & Africa

Table 91. Current Situation and Forecast of COVID-19 Drugs in Middle East & Africa

Table 92. Global COVID-19 Drugs Revenue Forecast by Type (2022-2028)

Table 93. Global COVID-19 Drugs Revenue Forecast by Application (2022-2028)

List of Figures

Figure 1. COVID-19 Drugs Picture

Figure 2. Global COVID-19 Drugs Revenue Market Share by Type in 2028

Figure 3. Tablet

Figure 4. Injection

Figure 5. COVID-19 Drugs Revenue Market Share by Application in 2028

Figure 6. Mild Symptom Patient Picture

Figure 7. Critically Ill Patient Picture

Figure 8. Global COVID-19 Drugs Market Size, (USD Million): 2022 VS 2028

Figure 9. Global COVID-19 Drugs Revenue and Forecast (2022-2028) & (USD Million)

Figure 10. COVID-19 Drugs Market Drivers

Figure 11. COVID-19 Drugs Market Restraints

Figure 12. COVID-19 Drugs Market Trends

Figure 13. Sanofi Recent Developments and Future Plans

Figure 14. Novartis Recent Developments and Future Plans

Figure 15. Shanghai Zhongxisanwei Recent Developments and Future Plans

Figure 16. Teva Recent Developments and Future Plans

Figure 17. Zydus Cadila Recent Developments and Future Plans

Figure 18. Mylan Recent Developments and Future Plans

Figure 19. Apotex Recent Developments and Future Plans

Figure 20. Advanz Pharma Recent Developments and Future Plans

Figure 21. Sun Pharma Recent Developments and Future Plans

Figure 22. Kyung Poong Recent Developments and Future Plans

Figure 23. Ipca Laboratories Recent Developments and Future Plans

Figure 24. Hanlim Pharmaceutical Recent Developments and Future Plans

Figure 25. Bristol Laboratories Recent Developments and Future Plans

Figure 26. Bayer Recent Developments and Future Plans

Figure 27. Rising Pharmaceutical Recent Developments and Future Plans

Figure 28. Shanghai Pharma Recent Developments and Future Plans

Figure 29. Sichuan Sunny Hope Recent Developments and Future Plans

Figure 30. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments and Future Plans

Figure 31. CSPC Group Recent Developments and Future Plans

Figure 32. KPC Group Recent Developments and Future Plans

Figure 33. Jinghua Pharmaceutical Group Recent Developments and Future Plans

Figure 34. Zhongsheng Pharma Recent Developments and Future Plans

Figure 35. North China Pharmaceutical Group Recent Developments and Future Plans

Figure 36. Global COVID-19 Drugs Revenue Market Share by Region (2022-2028)

Figure 37. Global COVID-19 Drugs Revenue Market Share by Region in 2028

Figure 38. North America COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)

Figure 39. Europe COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)

Figure 40. Asia-Pacific COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)

Figure 41. South America COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)

Figure 42. Middle East & Africa COVID-19 Drugs Revenue (USD Million) and Growth Rate (2022-2028)

Figure 43. Global COVID-19 Drugs Market Share Forecast by Type (2022-2028)

Figure 44. Global COVID-19 Drugs Market Share Forecast by Application (2022-2028)

Figure 45. Methodology

Figure 46. Research Process and Data Source